Background And Objective: Several software applications have been proposed in the past years as computational tools for assessing biomedical signals. Many of them are focused on heart rate variability series only, with their strengths and limitations depending on the necessity of the user and the scope of the application. Here, we introduce new software, named PyBioS, intended for the analysis of cardiovascular signals, even though any type of biomedical signal can be used. PyBioS has some functionalities that differentiate it from the other software.
Methods: PyBioS was developed in Python language with an intuitive, user-friendly graphical user interface. The basic steps for using PyBioS comprise the opening or creation (simulation) of signals, their visualization, preprocessing and analysis. Currently, PyBioS has 8 preprocessing tools and 15 analysis methods, the later providing more than 50 metrics for analysis of the signals' dynamics.
Results: The possibility to create simulated signals and save the preprocessed signals is a strength of PyBioS. Besides, the software allows batch processing of files, making the analysis of a large amount of data easy and fast. Finally, PyBioS has plenty of analysis methods implemented, with the focus on nonlinear and complexity analysis of signals and time series.
Conclusions: Although PyBioS is not intended to overcome all the necessities from users, it has useful functionalities that may be helpful in many situations. Moreover, PyBioS is continuously under improvement and several simulated signals, tools and analysis methods are still to be implemented. Also, a new module is being implemented on it to provide machine learning algorithms for classification and regression of data extracted from the biomedical signals.
Download full-text PDF |
Source |
---|---|
http://dx.doi.org/10.1016/j.cmpb.2020.105718 | DOI Listing |
Endocrinol Diabetes Metab
January 2025
Department of Endocrinology and Metabolism, Second Affiliated Hospital of Chongqing Medical University, Chongqing, China.
Objective: This study investigates the relationship between the albumin-to-creatinine ratio and diabetic retinopathy (DR) in US adults using NHANES data from 2009 to 2016. This study assesses the predictive efficacy of the urinary serum albumin-to-creatinine ratio (UACR/SACR Ratio) against traditional biomarkers such as the serum albumin-to-creatinine ratio (SACR) and urinary albumin-to-creatinine ratio (UACR) for evaluating DR risk. Additionally, the study explores the potential of these biomarkers, both individually and in combination with HbA1c, for early detection and risk stratification of DR.
View Article and Find Full Text PDFSemin Ophthalmol
January 2025
Department of Ophthalmology, The Affiliated Hospital of Qingdao University, Qingdao, China.
Purposes: This meta-analysis aims to systematically analyze the efficacy of low-level red light (LRL) therapy for myopia control and prevention in children.
Methods: All the data were searched from the PubMed, EMBASE, and the Cochrane Library. The Cochrane Handbook was used to evaluate the quality of the included studies.
Sleep
January 2025
Department of Psychology, Faculty of Science, Memorial University, St. John's, NL, Canada.
Study Objectives: Cancer-related fatigue is one of the most common symptoms in cancer survivors. Cognitive behavioural therapy for insomnia (CBT-I) can improve fatigue, but mechanisms are unclear. This secondary analysis of a randomized controlled trial evaluated whether CBT-I led to a significant improvement in fatigue, accounting for change in comorbid symptoms of insomnia, perceived cognitive impairment (PCI), anxiety, and depression.
View Article and Find Full Text PDFJ Crohns Colitis
January 2025
Servei d'Aparell Digestiu, Hospital Universitari Germans Trias i Pujol (Badalona, Catalonia, Spain).
Background And Aims: Inflammatory bowel disease (IBD) develops in genetically susceptible individuals exposed to certain environmental factors, of which only a few have been established. We aimed to assess whether bariatric surgery (BS) and severe obesity are associated with an increased risk of developing IBD.
Methods: Adults diagnosed with obesity or severe obesity between 2005 and 2020 were identified from the Catalan Health Surveillance System; those diagnosed with IBD prior to the diagnosis of obesity or severe obesity were excluded.
Paediatr Drugs
January 2025
Institute of Clinical Pharmacology, Peking University First Hospital, Beijing, China.
Background: This study aimed to provide a comprehensive review of adverse events (AEs) associated with factor Xa (FXa) inhibitors in pediatric patients.
Methods: We searched PubMed, Embase, Cochrane Library, ClinicalTrials.gov, and the European Union Clinical Trials Register for English-language records from the establishment of the database up to October 17, 2023.
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!